# Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants

> **NCT00308633** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 55 (—)

## Conditions studied

- Coronary Artery Disease (CAD)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00308633
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03-23
- **Primary completion:** 2007-12-28
- **Final completion:** —
- **Target enrollment:** 55 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00308633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00308633, "Endothelial Progenitor Cells and Nitric Oxide in Cardiac Rehabilitation Program Participants". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00308633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*